Hypersensitivity reactions in paclitaxel treatment of ovarian cancer patients.
Lehoczky
O
O
Gynecological Oncology Department, National Institute of Oncology, Budapest, XII, Ráth Gy.u. 7-9, Hungary, H-1122. lehoczky@oncol.hu
Bagaméri
Andrea
A
Udvary
J
J
Pulay
T
T
D000368:Aged; D000707:Anaphylaxis / Q000209:etiology*; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects* / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000209:etiology*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel / Q000009:adverse effects* / Q000627:therapeutic use
D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel